Branched-Chain Amino Acids and Pigment Epithelium-Derived Factor: Novel Therapeutic Agents for Hepatitis C Virus-Associated Insulin Resistance | Bentham Science
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Branched-Chain Amino Acids and Pigment Epithelium-Derived Factor: Novel Therapeutic Agents for Hepatitis C Virus-Associated Insulin Resistance

Author(s): T. Kawaguchi, S. Yamagishi and M. Sata

Volume 16, Issue 36, 2009

Page: [4843 - 4857] Pages: 15

DOI: 10.2174/092986709789909620

Price: $65

Open Access Journals Promotions 2
Abstract

Recent clinical studies have shown that patients with chronic liver disease are insulin resistant. Of all etiologies of chronic liver disease including non-alcoholic fatty liver disease, the one that causes the most sever insulin resistance is hepatitis C virus (HCV) infection. Since insulin resistance promotes inflammatory and fibrogenic reactions in the liver, thus leading to the development of liver cirrhosis and hepatocellular carcinoma (HCC) in patients with HCV infection, amelioration of insulin sensitivity may inhibit the progression of HCV-associated liver disease, and could improve the survival of these patients. HCV directly causes insulin resistance through HCV core protein-elicited proteasomal degradation of insulin receptor substrates and subsequent inactivation of intracellular insulin signaling molecules such as Akt. Furthermore, tumor necrosis factor-alpha (TNF-α) and/or triglyceride accumulation-induced nuclear factor-κB (NF-κB) activation in the liver is shown to play a role in insulin resistance in patients with HCV-related chronic liver disease as well. We, along with others, have recently found that branched-chain amino acids (BCAAs) and pigment epitheliumderived factor (PEDF) could improve the HCV-associated insulin resistance via suppression of NF-κB and preservation of insulin signaling pathway. In this review, we discuss the mechanisms for the actions of BCAAs and PEDF, and their clinical implications in insulin resistance of chronic liver disease in patients with HCV infection. We also discuss here which chemical structures could contribute to insulin-sensitization in patients with HCV infection.

Keywords: Hepatitis C virus, insulin resistance, branched-chain amino acids, pigment epithelium-derived factor, insulin receptor substrate, suppressor of cytokine signaling, nuclear factor-kappaB, peroxisome proliferator-activated receptor


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy